| Name | Title | Contact Details |
|---|
Cellerant Therapeutics is a clinical stage biotechnology company focused on developing human stem cell and antibody therapies for oncology applications and blood-related disorders. Cellerant`s programs include: CLT-008, an off-the-shelf cellular immunotherapy, under evaluation in a multicenter, open-label, randomized, controlled Phase 2 clinical trial in patients with de novo AML; CSC030-ADC, a preclinical monoclonal antibody drug conjugate that selectively targets and kills leukemic stem and blast cells responsible for initiating and maintaining disease; and CSC012, a preclinical monoclonal antibody targeting leukemic and pre-leukemic stem cells for acute leukemias and myelodysplastic syndromes. The Company is also developing next generation CAR product candidates leveraging its proprietary immunocellular therapy and antibody discovery and development platform.
Walls-Gore Reporting is a Annapolis, MD-based company in the Business Services sector.
EXPERIENCE YOU CAN TRUST Horizon Companies is a fully integrated privately-held real estate investment, development and asset management company. We were founded in 2004 and are headquartered in Atlanta, Georgia. We have extensive expertise in apartmen...
N Systems Inc is a Columbia, MD-based company in the Business Services sector.